Novel Lipid-Lowering Therapies and Cardiovascular Outcomes

Dyslipidemia is a well-established risk factor for atherosclerotic cardiovascular disease, and while statins remain the cornerstone of therapy, residual risk persists for many patients. The advent of novel lipid-lowering agents—including PCSK9 inhibitors, bempedoic acid, and ANGPTL3 inhibitors—offers potent LDL reduction beyond statin therapy. Additionally, therapies targeting triglyceride-rich lipoproteins and lipoprotein(a) are under active development, aiming to address previously untreatable risk factors.

Recent outcome trials have demonstrated substantial event reduction with these agents, particularly in high-risk populations. Beyond LDL lowering, attention is turning toward pleiotropic effects such as plaque stabilization and inflammation reduction. This track will explore the expanding therapeutic landscape, discuss barriers to access and cost-effectiveness, and examine integration into treatment guidelines. Participants will also gain insights into ongoing clinical trials that could redefine lipid management strategies in the coming decade.

    Related Conference of Novel Lipid-Lowering Therapies and Cardiovascular Outcomes

    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Tokyo, Japan
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands
    September 22-23, 2025

    14th World Heart Congress

    Dubai, UAE
    September 25-26, 2025

    13th International Conference on Hypertension and Healthcare

    Zurich, Switzerland
    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Novel Lipid-Lowering Therapies and Cardiovascular Outcomes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in